Search by Drug Name or NDC

    NDC 58406-0055-04 ENBREL 25 mg/.5mL Details

    ENBREL 25 mg/.5mL

    ENBREL is a SUBCUTANEOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Immunex Corporation. The primary component is ETANERCEPT.

    Product Information

    NDC 58406-0055
    Product ID 58406-055_29187b7c-d166-45e4-bc8c-4cbf71a67702
    Associated GPIs 66290030002015
    GCN Sequence Number 081339
    GCN Sequence Number Description etanercept VIAL 25MG/0.5ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 48417
    HICL Sequence Number 018830
    HICL Sequence Number Description ETANERCEPT
    Brand/Generic Brand
    Proprietary Name ENBREL
    Proprietary Name Suffix n/a
    Non-Proprietary Name etanercept
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/.5mL
    Substance Name ETANERCEPT
    Labeler Name Immunex Corporation
    Pharmaceutical Class Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA103795
    Listing Certified Through 2024-12-31

    Package

    NDC 58406-0055-04 (58406005504)

    NDC Package Code 58406-055-04
    Billing NDC 58406005504
    Package 4 VIAL, SINGLE-DOSE in 1 CARTON (58406-055-04) / .5 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2020-03-05
    NDC Exclude Flag N
    Pricing Information N/A